J9349 Injection., tafasitamab-cxix
J-Codes
Also known as: tafasitamab, Monjuvi
Injection of tafasitamab-cxix, a CD19-directed cytolytic T-cell engager. Bispecific antibody for B-cell lymphoma immunotherapy.
Clinical Context
Used for relapsed/refractory diffuse large B-cell lymphoma with lenalidomide. Bispecific antibody engaging T-cells to CD19-positive cells.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.